HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-APR-15 4Z8D TITLE ANTIBACTERIAL FABH INHIBITORS WITH VALIDATED MODE OF ACTION IN TITLE 2 HAEMOPHILUS INFLUENZAE BY IN VITRO RESISTANCE MUTATION MAPPING COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE III,BETA-KETOACYL- COMPND 5 ACP SYNTHASE III,KAS III; COMPND 6 EC: 2.3.1.180; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI O157:H7; SOURCE 3 ORGANISM_TAXID: 83334; SOURCE 4 GENE: FABH, Z1730, ECS1469; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BETA-KETOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE III, CARBAMATE, KEYWDS 2 STRUCTURE BASED DRUG DESIGN, FATTY ACID BIOSYNTHESIS, TRANSFERASE- KEYWDS 3 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.D.LAHIRI REVDAT 3 06-MAR-24 4Z8D 1 REMARK REVDAT 2 28-SEP-16 4Z8D 1 JRNL REMARK REVDAT 1 04-MAY-16 4Z8D 0 JRNL AUTH D.C.MCKINNEY,C.J.EYERMANN,R.F.GU,J.HU,S.L.KAZMIRSKI, JRNL AUTH 2 S.D.LAHIRI,A.R.MCKENZIE,A.B.SHAPIRO,G.BREAULT JRNL TITL ANTIBACTERIAL FABH INHIBITORS WITH MODE OF ACTION VALIDATED JRNL TITL 2 IN HAEMOPHILUS INFLUENZAE BY IN VITRO RESISTANCE MUTATION JRNL TITL 3 MAPPING. JRNL REF ACS INFECT DIS. V. 2 456 2016 JRNL REFN ESSN 2373-8227 JRNL PMID 27626097 JRNL DOI 10.1021/ACSINFECDIS.6B00053 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0103 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.0 REMARK 3 NUMBER OF REFLECTIONS : 33013 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.161 REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1753 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1069 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 37.28 REMARK 3 BIN R VALUE (WORKING SET) : 0.1860 REMARK 3 BIN FREE R VALUE SET COUNT : 55 REMARK 3 BIN FREE R VALUE : 0.2640 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4702 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : -0.03000 REMARK 3 B33 (A**2) : 0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.217 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.183 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.105 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.729 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4876 ; 0.016 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4624 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6639 ; 1.709 ; 1.962 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10620 ; 1.030 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 640 ; 6.682 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 194 ;36.539 ;24.381 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 771 ;13.068 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;20.420 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 784 ; 0.101 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5590 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1050 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2554 ; 1.156 ; 1.359 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2553 ; 1.154 ; 1.359 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3196 ; 1.748 ; 2.030 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4Z8D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000208807. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JAN-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X26C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34795 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 28.050 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.1 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25 MM TRIS PH 7.5, 150 MM NACL, 10% REMARK 280 GLYCEROL, 1MM TCEP, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.68500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.26500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.74800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.26500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.68500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.74800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O2 SO4 A 402 O HOH A 501 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 42 NE - CZ - NH1 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG B 17 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG B 17 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 GLU B 41 CB - CA - C ANGL. DEV. = -12.7 DEGREES REMARK 500 LYS B 256 CB - CA - C ANGL. DEV. = 16.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 82 32.95 -144.85 REMARK 500 ALA A 110 35.39 -142.50 REMARK 500 ALA A 111 -135.32 49.01 REMARK 500 LEU A 189 109.72 -161.50 REMARK 500 SER A 276 -122.13 55.92 REMARK 500 SER B 82 30.25 -144.28 REMARK 500 ALA B 110 34.75 -143.20 REMARK 500 ALA B 111 -130.43 46.82 REMARK 500 ASN B 198 -51.86 -166.59 REMARK 500 GLU B 200 -5.35 61.23 REMARK 500 GLN B 245 59.08 -110.58 REMARK 500 SER B 276 -123.30 57.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO B 172 GLY B 173 140.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 678 DISTANCE = 6.17 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4LB A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4LB B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 402 DBREF 4Z8D A 1 317 UNP P0A6R2 FABH_ECO57 1 317 DBREF 4Z8D B 1 317 UNP P0A6R2 FABH_ECO57 1 317 SEQRES 1 A 317 MET TYR THR LYS ILE ILE GLY THR GLY SER TYR LEU PRO SEQRES 2 A 317 GLU GLN VAL ARG THR ASN ALA ASP LEU GLU LYS MET VAL SEQRES 3 A 317 ASP THR SER ASP GLU TRP ILE VAL THR ARG THR GLY ILE SEQRES 4 A 317 ARG GLU ARG HIS ILE ALA ALA PRO ASN GLU THR VAL SER SEQRES 5 A 317 THR MET GLY PHE GLU ALA ALA THR ARG ALA ILE GLU MET SEQRES 6 A 317 ALA GLY ILE GLU LYS ASP GLN ILE GLY LEU ILE VAL VAL SEQRES 7 A 317 ALA THR THR SER ALA THR HIS ALA PHE PRO SER ALA ALA SEQRES 8 A 317 CYS GLN ILE GLN SER MET LEU GLY ILE LYS GLY CYS PRO SEQRES 9 A 317 ALA PHE ASP VAL ALA ALA ALA CYS ALA GLY PHE THR TYR SEQRES 10 A 317 ALA LEU SER VAL ALA ASP GLN TYR VAL LYS SER GLY ALA SEQRES 11 A 317 VAL LYS TYR ALA LEU VAL VAL GLY SER ASP VAL LEU ALA SEQRES 12 A 317 ARG THR CYS ASP PRO THR ASP ARG GLY THR ILE ILE ILE SEQRES 13 A 317 PHE GLY ASP GLY ALA GLY ALA ALA VAL LEU ALA ALA SER SEQRES 14 A 317 GLU GLU PRO GLY ILE ILE SER THR HIS LEU HIS ALA ASP SEQRES 15 A 317 GLY SER TYR GLY GLU LEU LEU THR LEU PRO ASN ALA ASP SEQRES 16 A 317 ARG VAL ASN PRO GLU ASN SER ILE HIS LEU THR MET ALA SEQRES 17 A 317 GLY ASN GLU VAL PHE LYS VAL ALA VAL THR GLU LEU ALA SEQRES 18 A 317 HIS ILE VAL ASP GLU THR LEU ALA ALA ASN ASN LEU ASP SEQRES 19 A 317 ARG SER GLN LEU ASP TRP LEU VAL PRO HIS GLN ALA ASN SEQRES 20 A 317 LEU ARG ILE ILE SER ALA THR ALA LYS LYS LEU GLY MET SEQRES 21 A 317 SER MET ASP ASN VAL VAL VAL THR LEU ASP ARG HIS GLY SEQRES 22 A 317 ASN THR SER ALA ALA SER VAL PRO CYS ALA LEU ASP GLU SEQRES 23 A 317 ALA VAL ARG ASP GLY ARG ILE LYS PRO GLY GLN LEU VAL SEQRES 24 A 317 LEU LEU GLU ALA PHE GLY GLY GLY PHE THR TRP GLY SER SEQRES 25 A 317 ALA LEU VAL ARG PHE SEQRES 1 B 317 MET TYR THR LYS ILE ILE GLY THR GLY SER TYR LEU PRO SEQRES 2 B 317 GLU GLN VAL ARG THR ASN ALA ASP LEU GLU LYS MET VAL SEQRES 3 B 317 ASP THR SER ASP GLU TRP ILE VAL THR ARG THR GLY ILE SEQRES 4 B 317 ARG GLU ARG HIS ILE ALA ALA PRO ASN GLU THR VAL SER SEQRES 5 B 317 THR MET GLY PHE GLU ALA ALA THR ARG ALA ILE GLU MET SEQRES 6 B 317 ALA GLY ILE GLU LYS ASP GLN ILE GLY LEU ILE VAL VAL SEQRES 7 B 317 ALA THR THR SER ALA THR HIS ALA PHE PRO SER ALA ALA SEQRES 8 B 317 CYS GLN ILE GLN SER MET LEU GLY ILE LYS GLY CYS PRO SEQRES 9 B 317 ALA PHE ASP VAL ALA ALA ALA CYS ALA GLY PHE THR TYR SEQRES 10 B 317 ALA LEU SER VAL ALA ASP GLN TYR VAL LYS SER GLY ALA SEQRES 11 B 317 VAL LYS TYR ALA LEU VAL VAL GLY SER ASP VAL LEU ALA SEQRES 12 B 317 ARG THR CYS ASP PRO THR ASP ARG GLY THR ILE ILE ILE SEQRES 13 B 317 PHE GLY ASP GLY ALA GLY ALA ALA VAL LEU ALA ALA SER SEQRES 14 B 317 GLU GLU PRO GLY ILE ILE SER THR HIS LEU HIS ALA ASP SEQRES 15 B 317 GLY SER TYR GLY GLU LEU LEU THR LEU PRO ASN ALA ASP SEQRES 16 B 317 ARG VAL ASN PRO GLU ASN SER ILE HIS LEU THR MET ALA SEQRES 17 B 317 GLY ASN GLU VAL PHE LYS VAL ALA VAL THR GLU LEU ALA SEQRES 18 B 317 HIS ILE VAL ASP GLU THR LEU ALA ALA ASN ASN LEU ASP SEQRES 19 B 317 ARG SER GLN LEU ASP TRP LEU VAL PRO HIS GLN ALA ASN SEQRES 20 B 317 LEU ARG ILE ILE SER ALA THR ALA LYS LYS LEU GLY MET SEQRES 21 B 317 SER MET ASP ASN VAL VAL VAL THR LEU ASP ARG HIS GLY SEQRES 22 B 317 ASN THR SER ALA ALA SER VAL PRO CYS ALA LEU ASP GLU SEQRES 23 B 317 ALA VAL ARG ASP GLY ARG ILE LYS PRO GLY GLN LEU VAL SEQRES 24 B 317 LEU LEU GLU ALA PHE GLY GLY GLY PHE THR TRP GLY SER SEQRES 25 B 317 ALA LEU VAL ARG PHE HET 4LB A 401 22 HET SO4 A 402 5 HET 4LB B 401 22 HET SO4 B 402 5 HETNAM 4LB TRANS-4-[({[(2-CHLOROBENZYL)OXY]CARBONYL}AMINO) HETNAM 2 4LB METHYL]CYCLOHEXANECARBOXYLIC ACID HETNAM SO4 SULFATE ION FORMUL 3 4LB 2(C16 H20 CL N O4) FORMUL 4 SO4 2(O4 S 2-) FORMUL 7 HOH *310(H2 O) HELIX 1 AA1 ASN A 19 LYS A 24 1 6 HELIX 2 AA2 SER A 29 GLY A 38 1 10 HELIX 3 AA3 THR A 50 GLY A 67 1 18 HELIX 4 AA4 GLU A 69 ILE A 73 5 5 HELIX 5 AA5 SER A 89 GLY A 99 1 11 HELIX 6 AA6 ALA A 110 CYS A 112 5 3 HELIX 7 AA7 ALA A 113 SER A 128 1 16 HELIX 8 AA8 VAL A 141 CYS A 146 1 6 HELIX 9 AA9 GLY A 183 GLU A 187 5 5 HELIX 10 AB1 ALA A 208 ASN A 231 1 24 HELIX 11 AB2 ASP A 234 LEU A 238 5 5 HELIX 12 AB3 ASN A 247 LEU A 258 1 12 HELIX 13 AB4 SER A 261 VAL A 265 5 5 HELIX 14 AB5 THR A 268 GLY A 273 1 6 HELIX 15 AB6 THR A 275 ALA A 277 5 3 HELIX 16 AB7 ALA A 278 ASP A 290 1 13 HELIX 17 AB8 ASN B 19 VAL B 26 1 8 HELIX 18 AB9 SER B 29 GLY B 38 1 10 HELIX 19 AC1 THR B 50 GLY B 67 1 18 HELIX 20 AC2 GLU B 69 ILE B 73 5 5 HELIX 21 AC3 SER B 89 LEU B 98 1 10 HELIX 22 AC4 ALA B 110 CYS B 112 5 3 HELIX 23 AC5 ALA B 113 SER B 128 1 16 HELIX 24 AC6 LEU B 142 CYS B 146 1 5 HELIX 25 AC7 ASP B 150 ILE B 155 1 6 HELIX 26 AC8 GLY B 183 GLU B 187 5 5 HELIX 27 AC9 ALA B 208 ASN B 231 1 24 HELIX 28 AD1 ASP B 234 LEU B 238 5 5 HELIX 29 AD2 ASN B 247 GLY B 259 1 13 HELIX 30 AD3 SER B 261 VAL B 265 5 5 HELIX 31 AD4 THR B 268 GLY B 273 1 6 HELIX 32 AD5 THR B 275 ALA B 277 5 3 HELIX 33 AD6 ALA B 278 ASP B 290 1 13 SHEET 1 AA110 TYR A 2 TYR A 11 0 SHEET 2 AA110 GLY A 160 SER A 169 -1 O SER A 169 N TYR A 2 SHEET 3 AA110 TYR A 133 ASP A 140 -1 N GLY A 138 O GLY A 162 SHEET 4 AA110 LEU A 75 ALA A 79 1 N ALA A 79 O VAL A 137 SHEET 5 AA110 ALA A 105 ALA A 109 1 O PHE A 106 N VAL A 78 SHEET 6 AA110 ALA B 105 ALA B 109 -1 O ASP B 107 N ALA A 109 SHEET 7 AA110 LEU B 75 ALA B 79 1 N VAL B 78 O VAL B 108 SHEET 8 AA110 TYR B 133 VAL B 141 1 O VAL B 137 N ALA B 79 SHEET 9 AA110 ASP B 159 SER B 169 -1 O LEU B 166 N ALA B 134 SHEET 10 AA110 TYR B 2 TYR B 11 -1 N TYR B 2 O SER B 169 SHEET 1 AA2 2 GLN A 15 THR A 18 0 SHEET 2 AA2 2 GLU A 41 ILE A 44 -1 O ARG A 42 N ARG A 17 SHEET 1 AA3 3 HIS A 85 PHE A 87 0 SHEET 2 AA3 3 LEU B 189 PRO B 192 -1 O LEU B 191 N PHE A 87 SHEET 3 AA3 3 THR B 206 MET B 207 -1 O THR B 206 N THR B 190 SHEET 1 AA4 4 ILE A 174 ALA A 181 0 SHEET 2 AA4 4 THR A 309 ARG A 316 -1 O LEU A 314 N ILE A 175 SHEET 3 AA4 4 LEU A 298 GLY A 305 -1 N GLY A 305 O THR A 309 SHEET 4 AA4 4 TRP A 240 PRO A 243 1 N VAL A 242 O LEU A 300 SHEET 1 AA5 3 THR A 206 MET A 207 0 SHEET 2 AA5 3 LEU A 189 PRO A 192 -1 N THR A 190 O THR A 206 SHEET 3 AA5 3 HIS B 85 PHE B 87 -1 O PHE B 87 N LEU A 191 SHEET 1 AA6 2 GLN B 15 THR B 18 0 SHEET 2 AA6 2 GLU B 41 ILE B 44 -1 O ARG B 42 N ARG B 17 SHEET 1 AA7 4 ILE B 174 ALA B 181 0 SHEET 2 AA7 4 THR B 309 ARG B 316 -1 O TRP B 310 N HIS B 180 SHEET 3 AA7 4 LEU B 298 GLY B 305 -1 N LEU B 301 O ALA B 313 SHEET 4 AA7 4 TRP B 240 VAL B 242 1 N VAL B 242 O LEU B 300 CISPEP 1 PHE A 87 PRO A 88 0 -5.51 CISPEP 2 PRO A 172 GLY A 173 0 2.16 CISPEP 3 GLY A 307 PHE A 308 0 0.21 CISPEP 4 PHE B 87 PRO B 88 0 -7.35 CISPEP 5 PRO B 199 GLU B 200 0 28.12 CISPEP 6 GLY B 307 PHE B 308 0 -6.69 SITE 1 AC1 15 ARG A 36 GLY A 209 VAL A 212 PHE A 213 SITE 2 AC1 15 ALA A 216 ALA A 246 ARG A 249 ILE A 250 SITE 3 AC1 15 ASN A 274 PHE A 304 HOH A 531 HOH A 554 SITE 4 AC1 15 HOH A 662 THR B 18 ALA B 20 SITE 1 AC2 5 THR A 177 LEU A 179 HOH A 501 HOH A 536 SITE 2 AC2 5 PRO B 104 SITE 1 AC3 15 TRP B 32 ARG B 36 ILE B 156 MET B 207 SITE 2 AC3 15 GLY B 209 ASN B 210 VAL B 212 PHE B 213 SITE 3 AC3 15 ALA B 216 ALA B 246 ILE B 250 ASN B 274 SITE 4 AC3 15 PHE B 304 HOH B 501 HOH B 537 SITE 1 AC4 6 LYS A 132 SER B 202 ILE B 203 HIS B 204 SITE 2 AC4 6 HOH B 531 HOH B 553 CRYST1 63.370 79.496 120.530 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015780 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012579 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008297 0.00000